Cargando…

Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial

The predictive value of serum adiponectin for hypertensive cardiovascular outcomes is unknown. This study was performed to investigate the association of adiponectin with incident cardiovascular and renal events (CV events) in hypertensive patients. We performed post-hoc analysis on 1,228 hypertensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim-Mitsuyama, Shokei, Soejima, Hirofumi, Yasuda, Osamu, Node, Koichi, Jinnouchi, Hideaki, Yamamoto, Eiichiro, Sekigami, Taiji, Ogawa, Hisao, Matsui, Kunihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851137/ https://www.ncbi.nlm.nih.gov/pubmed/31719604 http://dx.doi.org/10.1038/s41598-019-52977-x

Ejemplares similares

Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2018)

Reduction in hsCRP levels is associated with decreased incidence of cardiovascular events in Japanese hypertensive women but not in men
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2020)

The Authors Reply:
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)

An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)

Tissue Inhibitor of Metalloproteinase-3 Knockout Mice Exhibit Enhanced Energy Expenditure through Thermogenesis
por: Hanaoka, Yohsuke, et al.
Publicado: (2014)

Differential Effect of Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Diabetes Management: A subanalysis of the JPAD trial
por: Okada, Sadanori, et al.
Publicado: (2011)

Low-Dose Aspirin Therapy in Patients With Type 2 Diabetes and Reduced Glomerular Filtration Rate: Subanalysis from the JPAD trial
por: Saito, Yoshihiko, et al.
Publicado: (2011)

Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2012)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2013)

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis
por: Ishii, Mitsuru, et al.
Publicado: (2022)

Incremental Prognostic Significance of the Elevated Levels of Pentraxin 3 in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction
por: Matsubara, Junichi, et al.
Publicado: (2014)

Novel Mechanism for Disrupted Circadian Blood Pressure Rhythm in a Rat Model of Metabolic Syndrome—The Critical Role of Angiotensin II
por: Sueta, Daisuke, et al.
Publicado: (2013)

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
por: Kusaka, Hiroaki, et al.
Publicado: (2016)

Determinants of Myocardial Lactate Production During Acetylcholine Provocation Test in Patients With Coronary Spasm
por: Kaikita, Koichi, et al.
Publicado: (2015)

Erratum: ASK1 is involved in cognitive impairment caused by long-term high-fat diet feeding in mice
por: Toyama, Kensuke, et al.
Publicado: (2015)

ASK1 is involved in cognitive impairment caused by long-term high-fat diet feeding in mice
por: Toyama, Kensuke, et al.
Publicado: (2015)

Changes in the risk factors for coronary spasm
por: Ishii, Masanobu, et al.
Publicado: (2016)

Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm
por: Ishii, Masanobu, et al.
Publicado: (2016)

Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study
por: Okada, Sadanori, et al.
Publicado: (2016)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
por: Matsumoto, Chisa, et al.
Publicado: (2022)

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction
por: Ishii, Masanobu, et al.
Publicado: (2017)

Association of estimated central blood pressure measured non-invasively with pulse wave velocity in patients with coronary artery disease
por: Sueta, Daisuke, et al.
Publicado: (2015)

Effect of canagliflozin on white blood cell counts in patients with type 2 diabetes and heart failure: A subanalysis of the randomized CANDLE trial
por: Tanaka, Atsushi, et al.
Publicado: (2022)

H(2)FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors
por: Suzuki, Satoru, et al.
Publicado: (2020)

Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial
por: Hirai, Hiroyuki, et al.
Publicado: (2019)

Risk prediction score for clinical outcome in atrial fibrillation and stable coronary artery disease
por: Ishii, Masanobu, et al.
Publicado: (2023)

Comparing the Effects of Canagliflozin vs. Glimepiride by Body Mass Index in Patients with Type 2 Diabetes and Chronic Heart Failure: A Subanalysis of the CANDLE Trial
por: Sezai, Akira, et al.
Publicado: (2022)

Effect of febuxostat on the level of malondialdehyde‐modified low‐density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study
por: Teragawa, Hiroki, et al.
Publicado: (2023)

The impact of kidney function in patients on antithrombotic therapy: a post hoc subgroup analysis focusing on recurrent bleeding events from the AFIRE trial
por: Matsui, Kunihiko, et al.
Publicado: (2022)

Long‐Term Renal Denervation Normalizes Disrupted Blood Pressure Circadian Rhythm and Ameliorates Cardiovascular Injury in a Rat Model of Metabolic Syndrome
por: Katayama, Tetsuji, et al.
Publicado: (2013)

Multi-scale electronics transport properties in non-ideal CVD graphene sheet
por: Bishnoi, Bhupesh, et al.
Publicado: (2022)

Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease
por: Suzuki, Satoru, et al.
Publicado: (2020)

Serum Adiponectin and Leptin Is Not Related to Skeletal Muscle Morphology and Function in Young Women
por: Yoshiko, Akito, et al.
Publicado: (2023)

Antithrombotic Therapy for Atrial Fibrillation and Coronary Artery Disease in Patients With Prior Atherothrombotic Disease: A Post Hoc Analysis of the AFIRE Trial
por: Matsuzawa, Yasushi, et al.
Publicado: (2021)

Reactive Oxygen Metabolites are Closely Associated With the Diagnosis and Prognosis of Coronary Artery Disease
por: Hirata, Yoshihiro, et al.
Publicado: (2015)

Microvascular Coronary Artery Spasm Presents Distinctive Clinical Features With Endothelial Dysfunction as Nonobstructive Coronary Artery Disease
por: Ohba, Keisuke, et al.
Publicado: (2012)

Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings
por: Arashi, Hiroyuki, et al.
Publicado: (2022)

Rivaroxaban Monotherapy in Atrial Fibrillation and Stable Coronary Artery Disease Across Body Mass Index Categories
por: Ishii, Masanobu, et al.
Publicado: (2022)

Peripheral Endothelial Function and Cardiovascular Events in High‐Risk Patients
por: Matsuzawa, Yasushi, et al.
Publicado: (2013)

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
por: Kojima, Sunao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_531q64lmijijjfvnf502uvj7ao